The cardiovascular safety of oral semaglutide, a glucagon-like peptide ... including the first draft, under the direction of the authors; Beverly La Ferla, M.Res., and Helen Marshall, B.A ...

The medicines are being turned into a range of pills, gummies, melt-in-the-mouth strips and under-the-tongue drops. Tablets of semaglutide (currently sold in injectable form as Wegovy for obesity ...

Most common gastrointestinal issues seen were nausea/vomiting, abdominal pain, and diarrhea. HealthDay News — The rate of emergency department visits for adverse events among patients dispensed ...

The trial was sponsored by Novo Nordisk, the pharmaceutical company that manufactures semaglutide under brand names like Ozempic and Rybelsus. While the results are promising, researchers note ...

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

There’s limited scientific evidence directly linking semaglutide use to vitamin B12 deficiency or recommending routine vitamin B12 supplementation for people taking semaglutide. Semaglutide is ...

Semaglutide was initially approved under the brand name Ozempic for Type 2 diabetes, while the brand name Wegovy is only approved for weight loss. Here, we’ll compare tirzepatide (Zepbound ...

The large-scale study focused on use of semaglutide and non-GLP-1 RAs. An increased risk for nonarteritic anterior ischemic optic neuropathy with semaglutide was seen at 2, 3 and 4 years from the ...

stroke and CV death in those treated with oral semaglutide vs placebo. The proven cardiovascular benefit reflects a profound clinical impact for our patients who now have an oral option to improve ...